Senior Editor – Europe
Latest From David Ridley
Starpharma's COVID-busting Viraleze antiviral nasal spray will soon be available across Europe, included the UK. But will it fall foul of local evidence requirements, for example in France, where the country's medicines agency has halted the sale of Pharma & Beauty (P&B) Group's COV-Defense spray until its efficacy against COVID has been confirmed by human-based studies?
HBW Insight speaks to Johnson & Johnson's Bill Twomey and Sven Sjovall about how one of the biggest OTC launches of 2020 – Nicorette QuickMist SmartTrack – uses behavioral science techniques to help motivate consumers to quit smoking and overcame COVID-related supply chain difficulties to launch a much-needed digital smoking cessation aid in the middle of a pandemic.
Johnson & Johnson's market leading nicotine replacement brand, Nicorette, is at the forefront of the company's global sustainability strategy, which includes eradicating smoking entirely from the world and greening its Consumer Health business soon as possible.
Perrigo's NiQuitin NRT brand partners with the British Lung Foundation (BLF) to improve air quality in the UK. Meanwhile, two-thirds of UK smokers want to quit as a result of the pandemic.
In Germany, the coronavirus accelerated the shift towards online pharmacy and has strengthened certain OTC categories in 2020. Sales of hand sanitizers and vitamin and mineral supplements jumped while cough, cold and flu purchases weakened. Exploring the 2020 data, Sempora Consulting offers its advice for companies looking to adapt their strategies to the new reality.
Bayer Consumer Health claims UK OTC industry first with "actionable ad" for its Berocca Boost dispersible vitamin and mineral supplement.